Diagnostic test accuracy of serum anti-PLA2R autoantibodies and glomerular PLA2R antigen for diagnosing idiopathic membranous nephropathy: an updated meta …

W Li, Y Zhao, P Fu - Frontiers in Medicine, 2018 - frontiersin.org
Background M-type phospholipase A2 receptor (PLA2R) is known as a major antigen on
podocytes, which is involved with the pathogenesis of idiopathic membranous nephropathy …

Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: the optimal cut-off value for Chinese patients

Y Liu, X Li, C Ma, P Wang, J Liu, H Su, H Zhuo… - Clinica Chimica …, 2018 - Elsevier
Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …

Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience

B Porcelli, A Guarnieri, F Ferretti, G Garosi… - Journal of …, 2021 - Springer
Background Autoantibodies against-phospholipase A2 receptor (PLA2R) are specific
markers of idiopathic membranous nephropathy (iMN). Enzyme-linked immunosorbent …

[HTML][HTML] Comparison of performance and clinical utility of different methods for detecting anti-PLA2R antibody

T Wang, M Wang, W Yu, H Li, Z Zhao, J Shang - Clinica Chimica Acta, 2023 - Elsevier
Objectives This study aimed to compare the performance of enzyme-linked immunosorbent
assay (ELISA) and magnetic particle chemiluminescence immunoassay (MP-CLIA) for …

Anti-phospholipase A2 receptor antibody screening in nephrotic syndrome may identify a distinct subset of patients with primary membranous nephropathy

R Jurubiță, B Obrișcă, C Achim, G Micu… - … Urology and Nephrology, 2022 - Springer
Purpose We sought to investigate the utility of anti-PLA2R antibody as a non-invasive
screening method for the diagnosis of primary MN in patients with nephrotic syndrome (NS) …

Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA

H Kaga, A Komatsuda, S Yamamoto, T Kikuchi… - Clinical and …, 2019 - Springer
Background The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70–80% in early studies on idiopathic membranous …

Diagnostic efficacy of serum anti-phospholipase A2 receptor antibodies for idiopathic membranous nephropathy in patients with diabetic kidney disease

Q Wang, Z Dong, W Zhang, X Liu, Y Qu, S Duan… - Clinica Chimica …, 2020 - Elsevier
Aim Serum anti-phospholipase A2 receptor (anti-PLA2R) antibodies are highly accurate in
diagnosing idiopathic membranous nephropathy (IMN) in populations with kidney disease …

Optimal value for serum anti-PLA2R antibody in primary membranous nephropathy: a multicenter observational study

J Chen, X Jia, X Wei, J Li, Y Liu, Y Lian, Z Cui… - American Journal of …, 2022 - karger.com
Introduction: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is highly specific for
primary membranous nephropathy (PMN). Here, we compare the diagnostic value of …

Validation of phospholipase A2 receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis

P Dai, D Campbell, S Culican, DA Brown, K Byth… - Pathology, 2020 - Elsevier
Distinguishing between primary and secondary subtypes of membranous
glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared …

Anti-phospholipase A2 receptor antibody in membranous nephropathy; an Indian experience

M Yachha, RK Sharma, S Mehrotra… - Journal of Renal Injury …, 2017 - journalrip.com
Introduction: Autoantibodies against phospholipase-A2 Receptor (PLA2 R), a normally
occurring antigen presented on podocyte membranes, have recently been implicated in the …